Ligand Pharmaceuticals Insider Sold Shares Worth $1,430,434, According to a Recent SEC Filing

MT newswire2026/09/09 07:56

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

03:56 AM EDT, 09/09/2026 (MT Newswires) -- Andrew Reardon, Chief Legal Officer & Secretary, on September 03, 2026, sold 5,000 shares in Ligand Pharmaceuticals (LGND) for $1,430,434. Following the Form 4 filing with the SEC, Reardon has control over a total of 36,514 common shares of the company, with 36,514 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/886163/000200101126000137/xslF345X05/edgardoc.xml

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Ligand Pharmaceuticals Insider Sold Shares Worth $1,430,434, According to a Recent SEC Filing

You may also like

Crypto prices